How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Scientific method is a body of techniques for investigating phenomena, acquiring new knowledge, or correcting and integrating previous knowledge. It is based on gathering observable, empirical and ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Geophysics is the study of earth through the collection and analysis of physical property measurements that are recorded at or near the ground surface. Thus, geophysical methods include a vast array ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Recent insider activity at Recursion Pharmaceuticals included 2 transactions totaling $97,222.74. 1 tax payment and 1 sale were reported, with the sale representing $78,822.38 of the total.

Liquid AI released d1-ultra, a text and image decision model that returns calibrated probabilities in 1 forward pass. It ...

In the field of artificial intelligence, machine learning is a branch that uses data and algorithms to imitate human learning ...